Moderna (MRNA) Tops Q1 EPS by $3.37, Revenue Beats

Moderna (NASDAQ: MRNA) reported Q1 EPS of $8.58, $3.37 better than the analyst estimate of $5.21. Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $4.62 billion.

For earnings history and earnings-related data on Moderna (MRNA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Hitachi Ltd. (HIT) Misses Q2 EPS by 7c
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c